Should we routinely use mupirocin to prevent staphylococcal infections?

Virginia R. Roth, Cathryn Murphy, Trish M. Perl, Alfred DeMaria, Annette H. Sohn, Ronda L. Sinkowitz-Cochran, William R. Jarvis

Research output: Contribution to journalArticle

3 Scopus citations

Abstract

Routine use of mupirocin to prevent staphylococcal infections is controversial. We assessed attitudes and practices of healthcare professionals attending the Fourth Decennial International Conference on Nosocomial and Healthcare-Associated Infections regarding mupirocin prophylaxis. Eighty percent of participants did not use mupirocin routinely. At the end of the session, 58% indicated they would consider increased use of mupirocin.

Original languageEnglish (US)
Article number04423
Pages (from-to)745-749
Number of pages5
JournalInfection Control and Hospital Epidemiology
Volume21
Issue number11
DOIs
StatePublished - Nov 2000

    Fingerprint

ASJC Scopus subject areas

  • Epidemiology
  • Microbiology (medical)
  • Infectious Diseases

Cite this

Roth, V. R., Murphy, C., Perl, T. M., DeMaria, A., Sohn, A. H., Sinkowitz-Cochran, R. L., & Jarvis, W. R. (2000). Should we routinely use mupirocin to prevent staphylococcal infections? Infection Control and Hospital Epidemiology, 21(11), 745-749. [04423]. https://doi.org/10.1086/501720